Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp EV/Revenue

The EV/Revenue (Enterprise Value to Revenue) of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Nov 7, 2026 is 8.03. In the previous year, EV/Revenue (Enterprise Value to Revenue) was 6.45 — a change of 24.49% (higher).

EV/Revenue

8.03

YoY

24.49%

Last updated:

EV/Revenue (Enterprise Value to Revenue) of Vcanbio Cell & Gene Engineering Corp is 2025 8.03 . EV/Revenue (Enterprise Value to Revenue) of Vcanbio Cell & Gene Engineering Corp was 2024 6.45 . It decreases by 24.49% higher compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp EV/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/Revenue
Date
EV/Revenue
Jan 1, 2018
8.55 CNY
Jan 1, 2019
7.78 CNY
Jan 1, 2020
8.14 CNY
Jan 1, 2021
6.89 CNY
Jan 1, 2022
6.70 CNY
Jan 1, 2023
6.43 CNY
Jan 1, 2024
6.45 CNY
Jan 1, 2025
8.03 CNY
The Vcanbio Cell & Gene Engineering Corp EV/Revenue history
YEAREV/RevenueYoY
8.03+24.49%
6.45+0.36%
6.43-4.08%
6.70-2.71%
6.89-15.37%
8.14+4.64%
7.78-9.06%
8.55-2.70%
8.79-35.33%
13.59-13.88%
15.78-31.36%
22.99—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

EV/Revenue (Enterprise Value to Revenue) of Vcanbio Cell & Gene Engineering Corp is 8.03 in 2025.

EV/Revenue (Enterprise Value to Revenue) of Vcanbio Cell & Gene Engineering Corp changed from 6.45 to 8.03, representing a 24.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/Revenue (Enterprise Value to Revenue) Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

The EV/Revenue ratio compares a company's enterprise value to its total revenue. It is particularly useful for valuing high-growth companies that may not yet be profitable.

To evaluate EV/Revenue (Enterprise Value to Revenue)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/Revenue (Enterprise Value to Revenue).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/Revenue (Enterprise Value to Revenue)'s Vcanbio Cell & Gene Engineering Corp with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Vcanbio Cell & Gene Engineering Corp

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Vcanbio Cell & Gene Engineering Corp